News
Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, Alpha-X & Alpha DRK and Montréal ExchangeToronto, Ontario--(Newsfile Corp. - May 14, 2025) - TMX Group Limited today announced April 2 ...
Titan Mining Corporation (TSX: TI, OTCQB: TIMCF) ("Titan" or the "Company") today announced its financial and operating ...
Paris, 14 May 2025 - The Combined Annual General Meeting of JCDecaux SE (Euronext Paris: DEC) was held on 14 May 2025 at the company's head office. The Annual General Meeting (AGM) approved all the ...
Results for the first quarter ending 31 March 2025 Financial highlights Strong underlying[1] business growth offsetting lower ...
Oneida commenced operations. Baltic Power and Hai Long projects continue to make construction progress. TORONTO, May 13, 2025 ...
Highlights Show Continued Growth and Operating Profitability. Irvine, CA, May 14, 2025 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," PINK: FDCT), a fintech-driven firm specializing ...
Affirms sequential quarterly revenue growth target throughout 2025 MIGDAL HAEMEK, Israel, May 14, 2025 (GLOBE NEWSWIRE) -- Tower Semiconductor (NASDAQ/TASE: TSEM) reports ...
Non-GAAP Net Income $5.24 million; Non-GAAP EPS $1.5; Record Gross Margin 63.3% TEL AVIV, Israel, May 14, 2025 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global ...
Sow Good Inc. (Nasdaq: SOWG) ("Sow Good" or "the Company"), a trailblazer in the freeze dried candy and treat industry, is reporting financial and operating ...
PRISM resolves bottlenecks limiting the growth of AI training and inference by eliminating all electrical packet switches and all associated hardware from the network Oriole Networks, a London-based ...
Originally published on PSEG ENERGIZE! NORTHAMPTON, MA / ACCESS Newswire / May 14, 2025 / Protecting the Earth isn't just about today - it's about creating a better tomorrow for generations to come. A ...
TURKU, FINLAND / ACCESS Newswire / May 14, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN):Faron Pharmaceuticals Ltd. (AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results